Diclofenac Explained

Verifiedfields:changed
Watchedfields:changed
Verifiedrevid:443636249
Width:250
Width2:250
Tradename:Cataflam, Voltaren, Zipsor, others
Dailymedid:Diclofenac
Pregnancy Au:C
Pregnancy Au Comment:[1]
Routes Of Administration:By mouth, rectal, intramuscular, intravenous, topical
Atc Prefix:D11
Atc Suffix:AX18
Atc Supplemental:,,
Legal Au:S4
Legal Au Comment:/ S3 / S2
Legal Ca:Rx-only
Legal Ca Comment:[2]
Legal Uk:POM
Legal Uk Comment:/ P / GSL
Legal Us:Rx-only
Legal Us Comment:/ OTC[3]
Legal Status:Rx-only
Protein Bound:More than 99%
Metabolism:Liver, oxidative, primarily by CYP2C9, also by CYP2C8, CYP3A4, as well as conjugative by glucuronidation (UGT2B7) and sulfation;[4] no active metabolites exist
Onset:Within 4 hours (gel),[5] 30 min (non-gel)
Elimination Half-Life:1.2–2 h (35% of the drug enters enterohepatic recirculation)
Excretion:35% bile, 65% urine[6]
Cas Number:15307-86-5
Pubchem:3033
Iuphar Ligand:2714
Drugbank:DB00586
Chemspiderid:2925
Unii:144O8QL0L1
Kegg:D07816
Chebi:47381
Chembl:139
Pdb Ligand:DIF
Iupac Name:[2-(2,6-Dichloroanilino)phenyl]acetic acid
C:14
H:11
Cl:2
N:1
O:2
Smiles:O=C(O)Cc1ccccc1Nc2c(Cl)cccc2Cl
Stdinchi:1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)
Stdinchikey:DCOPUUMXTXDBNB-UHFFFAOYSA-N

Diclofenac (pronounced or [7]), sold under the brand name Voltaren, among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout.[8] It is taken by mouth or rectally in a suppository, used by injection, or applied to the skin.[8] [9] Improvements in pain last for as much as eight hours.[8] It is also available in combination with misoprostol in an effort to decrease stomach problems.

Common side effects include abdominal pain, gastrointestinal bleeding, nausea, dizziness, headache, and swelling.[8] Serious side effects may include heart disease, stroke, kidney problems, and stomach ulceration.[8] Use is not recommended in the third trimester of pregnancy.[8] It is likely safe during breastfeeding. Diclofenac is believed to work by decreasing the production of prostaglandins, like other drugs in this class.[10]

In 2021, diclofenac was the 61st most commonly prescribed medication in the United States, with more than 11million prescriptions.[11] [12] It is available as its acid or in two salts, as either diclofenac sodium or potassium.[13]

It is also widely used for livestock; such use was responsible for the Indian vulture crisis, during which in a few years 95% of the country's vulture population was killed, and in many countries agricultural use is now forbidden.[14] [15]

Medical uses

Diclofenac is used to treat pain related to arthritis, dysmenorrhea, rheumatic diseases and other inflammatory disorders,[8] [16] kidney stones and gallstones. An additional indication is the treatment of acute migraines.[17] Diclofenac is used commonly to treat mild to moderate postoperative or post-traumatic pain, in particular when inflammation is also present.[16]

Diclofenac is also available in topical forms and has been found to be useful for osteoarthritis but not other types of long-term musculoskeletal pain.[18] Diclofenac may also help with actinic keratosis and with acute pain caused by minor strains, sprains and contusions.[19]

In many countries, eye drops are sold to treat acute and chronic nonbacterial inflammation of the anterior part of the eyes (such as postoperative states).[20] The eye drops have also been used to manage pain for traumatic corneal abrasion.[21]

Diclofenac is often used to treat chronic pain associated with cancer, especially if inflammation is present.[22] Use of diclofenac gel should not exceed in a day.[23]

Contraindications

Adverse effects

See also: Nonsteroidal anti-inflammatory drug. Diclofenac consumption has been associated with significantly increased vascular and coronary risk in a study including coxib, diclofenac, ibuprofen and naproxen.[25] Upper gastrointestinal complications were also reported. Major adverse cardiovascular events were increased by about a third by diclofenac, chiefly due to an increase in major coronary events. Compared with placebo, of 1000 patients allocated to diclofenac for a year, three more had major vascular events, one of which was fatal. Vascular death is increased significantly by diclofenac.

In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in fetuses that result in low amniotic fluid. They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.[26] [27]

Heart

In 2013, a study found major vascular events were increased by about a third by diclofenac, chiefly due to an increase in major coronary events. Compared with placebo, of 1000 people allocated to diclofenac for a year, three more had major vascular events, one of which was fatal. Vascular death was increased by diclofenac (1·65).

Following the identification of increased risks of heart attacks with the selective COX-2 inhibitor rofecoxib in 2004, attention has focused on all the other members of the NSAIDs group, including diclofenac. Research results are mixed, with a meta-analysis of papers and reports up to April 2006 suggesting a relative increased rate of heart disease of 1.63 compared to nonusers.[28] Professor Peter Weissberg, medical director of the British Heart Foundation said, "However, the increased risk is small, and many patients with chronic debilitating pain may well feel that this small risk is worth taking to relieve their symptoms". Only aspirin was found not to increase the risk of heart disease; however, this is known to have a higher rate of gastric ulceration than diclofenac. In Britain the Medicines and Healthcare products Regulatory Agency (MHRA) said in June 2013 that the drug should not be used by people with serious underlying heart conditionspeople who had had heart failure, heart disease or a stroke were advised to stop using it completely.[29] As of 15 January 2015, the MHRA announced that diclofenac will be reclassified as a prescription-only medicine (POM) due to the risk of cardiovascular adverse events.[30]

A subsequent large study of 74,838 Danish users of NSAIDs or coxibs found no additional cardiovascular risk from diclofenac use.[31] A very large study of 1,028,437 Danish users of various NSAIDs or coxibs found the "Use of the nonselective NSAID diclofenac and the selective cyclooxygenase-2 inhibitor rofecoxib was associated with an increased risk of cardiovascular death (odds ratio, 1.91; 95% confidence interval, 1.62 to 2.42; and odds ratio, 1.66; 95% confidence interval, 1.06 to 2.59, respectively), with a dose-dependent increase in risk."[32]

Diclofenac is similar in COX-2 selectivity to celecoxib.[33]

Gastrointestinal

Liver

Kidney

Mental health

Pharmacology

As with most NSAIDs, the primary mechanism responsible for its anti-inflammatory, antipyretic and analgesic action is thought to be inhibition of prostaglandin synthesis through COX-inhibition. Diclofenac inhibits COX-1 and COX-2 with relative equipotency.[38]

The main target in inhibition of prostaglandin synthesis appears to be the transiently expressed prostaglandin-endoperoxide synthase-2 (PGES-2), also known as cycloxygenase-2 (COX-2). That is, diclofenac is partially selective for COX-2. It inhibits COX-2 approximately four times as much as COX-1.[39]

The drug may be bacteriostatic via inhibiting bacterial DNA synthesis.[40]

Diclofenac has a relatively high lipid solubility, making it one of the few NSAIDs that are able to enter the brain by crossing the blood-brain barrier.[41] As in the rest of the body, it is thought to exert its effect in the brain through inhibition of COX-2.[41] In addition, it may have effects inside the spinal cord.[42]

Diclofenac may be a unique member of the NSAIDs in other aspects. Some evidence indicates it inhibits the lipoxygenase pathways,[43] [44] thus reducing formation of leukotrienes (also pro-inflammatory autacoids). It also may inhibit phospholipase A2, which may be relevant to its mechanism of action. These additional actions may explain its high potency – it is the most potent NSAID on a broad basis.[45]

Marked differences exist among NSAIDs in their selective inhibition of the two subtypes of cyclooxygenase, COX-1 and COX-2.[46] Drug developers have focused on selective COX-2 inhibition, particularly as a way to minimize the gastrointestinal side effects of NSAIDs. In practice, use of some COX-2 inhibitors with their adverse effects has led to massive numbers of lawsuits alleging wrongful death by heart attack, yet other significantly COX-selective NSAIDs, such as diclofenac, have been well tolerated by most of the population.

Besides the COX-inhibition, a number of other molecular targets of diclofenac possibly contributing to its pain-relieving actions have recently been identified. These include:

The duration of action (i.e., duration of pain relief) of a single dose is longer (6 to 8 h) than the drug’s 1.2–2 h half-life. This could be partly because it persists for over 11 hours in synovial fluids.[51]

History

Diclofenac was first synthesized by Alfred Sallmann and Rudolf Pfister in 1973.[52] [53] The name "diclofenac" derives from its chemical name: 2-(2,6-dichloranilino) phenylacetic acid. It was patented in Germany in 1978 by Ciba-Geigy (now Novartis).[54] [55] It came into medical use in the United States in 1988.[8] GlaxoSmithKline purchased the rights in 2015. Currently, it is available as a generic drug.[8]

Society and culture

Formulations and brand names

Diclofenac formulations are available worldwide under many different brand names.[56]

Voltaren and Voltarol contain the sodium salt of diclofenac. In the United Kingdom, Voltarol can be supplied with either the sodium salt or the potassium salt, while Cataflam, sold in some other countries, is the potassium salt only. However, Voltarol Emulgel contains diclofenac diethylammonium 1.16%, being equivalent to 1% sodium salt. In 2016, Voltarol was one of the biggest selling branded over-the-counter medications sold in Great Britain, with sales of £39.3 million.[57]

In the United States, 1% diclofenac gel was approved by the FDA in 2007 as a prescription drug for the temporary relief of the pain of osteoarthritis of joints in the hands, knees and feet. In 2020, the FDA approved the gel formulation for nonprescription use.[3]

In January 2015, diclofenac oral preparations were reclassified as prescription-only medicines in the UK. The topical preparations are available without prescription.[58]

Ecological effects

See main article: Indian vulture crisis.

Use of diclofenac for animals is controversial due to toxicity when eaten by scavenging birds that eat dead animals;[14] [59] the medication has been banned for veterinary use in several countries.[15]

Use of diclofenac in animals has been reported to have led to a sharp decline in the vulture population in the Indian subcontinent – a 95% decline by 2003[60] and a 99.9% decline by 2008. The mechanism is presumed to be kidney failure;[61] however, toxicity may be due to direct inhibition of uric acid secretion in vultures.[62] Vultures eat the carcasses of livestock that have been administered veterinary diclofenac, and are poisoned by the accumulated chemical,[63] as vultures do not have a particular enzyme to break down diclofenac. At a meeting of the National Wildlife Board in March 2005, the Government of India announced it intended to phase out the veterinary use of diclofenac.[64] Meloxicam is a safer alternative to replace use of diclofenac.[65] It is more expensive than diclofenac, but the cost is dropping as more pharmaceutical companies are beginning to manufacture it.

Steppe eagles have the same vulnerability to diclofenac as Old World vultures, and are therefore at a similar risk from its effects.[66] Diclofenac has been shown also to harm freshwater fish species such as rainbow trout.[67] [68] [69] [70] In contrast, New World vultures, such as the turkey vulture, can tolerate at least 100 times the level of diclofenac that is lethal to Gyps species.[71]

"The loss of tens of millions of vultures over the last decade has had major ecological consequences across the Indian subcontinent that pose a potential threat to human health. In many places, populations of feral dogs have increased sharply from the disappearance of Gyps vultures as the main scavenger of wild and domestic ungulate carcasses. Associated with the rise in dog numbers is an increased risk of rabies"[65] and casualties of almost 50,000 people.[72] The Government of India cites this as one of the major consequences of a vulture species extinction.[64] A major shift in the transfer of corpse pathogens from vultures to feral dogs and rats could lead to a disease pandemic, causing millions of deaths in a crowded country like India, whereas vultures' digestive systems safely destroy many species of such pathogens. Vultures are long-lived and slow to breed. They start breeding only at the age of six and only 50% of their young survive. Even if the government ban is fully implemented, it will take many years to revive the vulture population.[73]

The loss of vultures has had a social impact on the Indian Zoroastrian Parsi community, who traditionally use vultures to dispose of human corpses in Towers of Silence, but are now compelled to seek alternative methods of disposal.[65]

Despite the vulture crisis, diclofenac remains available in other countries including many in Europe.[74] It was controversially approved for veterinary use in Spain in 2013 and continues to be available, despite Spain being home to around 90% of the European vulture population and an independent simulation showing that the drug could reduce the population of vultures by 1–8% annually. Spain's medicine agency presented simulations suggesting that the number of deaths would be quite small.[36] [75] A paper published in 2021 identified the first authenticated death of a vulture from diclofenac in Spain, a cinereous vulture.[59] [76]

Diclofenac is on the European Union's watch list because it pollutes the Baltic Sea. When the substance enters freshwater, it has an environmental impact and is considered more difficult to remove in wastewater treatment plants than, for example, ibuprofen.[77] Harmful residues have been found in blue mussels and fish, among others, where it has been found to cause damage to internal organs such as the gills, kidneys and liver.[78]

Veterinary use

Though its use in veterinary medicine is banned in some countries,[14] [59] [15] diclofenac is approved as a veterinary medication in others; it is used in the treatment of pets as well as in livestock. In some species of birds, diclofenac causes accumulation of uric acid crystals in internal organs—especially the liver and kidneys—resulting in visceral gout, as well as cellular damage and necrosis.[79] In South Asia in the 2000s, vulture populations were decimated after feeding on carcasses of livestock that had been treated with diclofenac.[36]

Notes and References

  1. Web site: Diclofenac Use During Pregnancy. Drugs.com. 16 January 2000. 18 February 2024.
  2. Web site: Product monograph brand safety updates . . 6 June 2024 . 8 June 2024.
  3. Web site: FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process. Food and Drug Administration. 14 February 2020. 18 February 2024.
  4. Web site: Diclofenac Oral Uses, Dosage, Side Effects And Composition. Medicine Reviews Agency. Sayyad M. 23 August 2018. 18 February 2024. 24 August 2018. https://web.archive.org/web/20180824135214/https://www.medicinereviews.ooo/2018/08/diclofenac-oral-uses-dosage-side.html. dead.
  5. Web site: How Long Does It Take for Voltaren Gel to Work?. YouDrugstore. 18 February 2024.
  6. Book: Williams BS, Buvanendran A. Nonopioid analgesics: NSAIDs, COX-2 inhibitors, and acetaminophen. 1 January 2011. https://www.sciencedirect.com/science/article/pii/B9781437722420000262. Essentials of Pain Medicine. 3. 130–139. Benzon HT, Raja SN, Liu SS, Fishman SM. W.B. Saunders. 10.1016/b978-1-4377-2242-0.00026-2. 978-1-4377-2242-0. 10 January 2023. 10 January 2023. https://web.archive.org/web/20230110202200/https://www.sciencedirect.com/science/article/pii/B9781437722420000262. live.
  7. Book: Mosby's Dictionary of Medicine, Nursing & Health Professions. O'Toole MT . 536 . 10th . 2017 . Elsevier. 978-0-323-22205-1.
  8. Web site: Diclofenac epolamine Monograph for Professionals. Drugs.com. 18 February 2024.
  9. Chung CH. The use of Injectable Nonsteroidal Anti-Inflammatory Drugs in Local Accident & Emergency Practice. Hong Kong Journal of Emergency Medicine. 2017. 9. 2. 65–71. 10.1177/102490790200900201. 74032271.
  10. Book: Mosby's Drug Reference for Health Professions. 2017. Elsevier Health Sciences. 978-0-323-56682-7. 398.
  11. Web site: The Top 300 of 2021. ClinCalc. 14 January 2024. 15 January 2024. https://web.archive.org/web/20240115223848/https://clincalc.com/DrugStats/Top300Drugs.aspx. live.
  12. Web site: Diclofenac – Drug Usage Statistics. ClinCalc. 18 February 2024.
  13. Book: British national formulary : BNF 74. 2017. British Medical Association. 978-0-85711-298-9. 1033–1035. 74.
  14. Cuthbert RJ, Taggart MA, Prakash V, Chakraborty SS, Deori P, Galligan T, Kulkarni M, Ranade S, Saini M, Sharma AK, Shringarpure R, Green RE. Avian scavengers and the threat from veterinary pharmaceuticals. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369. 1656. 20130574. 2014. 25405963. 4213586. 10.1098/rstb.2013.0574.
  15. News: McKie R. Rare European vultures being poisoned by livestock drug. 16 April 2022 . The Guardian. 11 April 2021. ...diclofenac has already been banned in India, Pakistan, Nepal and Bangladesh. 16 April 2022. https://web.archive.org/web/20220416025605/https://www.theguardian.com/environment/2021/apr/11/rare-european-vultures-being-poisoned-by-livestock-drug. live.
  16. Web site: Rufenal. Birzeit Pharmaceutical Company. dead. https://web.archive.org/web/20110526184251/http://www.bpc.ps/products/prod_desc/72.html. 26 May 2011.
  17. Web site: Patient Site – Cambia (diclofenac potassium) for oral solution. cambiarx.com. 16 August 2011. https://web.archive.org/web/20110816014707/http://www.cambiarx.com/. live.
  18. Dutta NK, Mazumdar K, Dastidar SG, Park JH. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. International Journal of Antimicrobial Agents. 30. 4. 336–340. 2007. 17644321. 10.1016/j.ijantimicag.2007.04.016.
  19. Web site: Diclofenac (Topical Application Route) Description and Brand Names . MayoClinic.com . . 23 November 2013 . https://web.archive.org/web/20131123224442/http://www.mayoclinic.com/health/drug-information/DR600545 . live .
  20. Web site: Naclof, oogdruppels 1 mg/ml . https://web.archive.org/web/20160304033446/http://db.cbg-meb.nl/IB-teksten/h12800.pdf . 4 March 2016 . Laboratoires THEA . Netherlands Medicines Authority MEB . Medicines Information Bank . Netherlands.
  21. Wakai A, Lawrenson JG, Lawrenson AL, Wang Y, Brown MD, Quirke M, Ghandour O, McCormick R, Walsh CD, Amayem A, Lang E, Harrison N . Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions . The Cochrane Database of Systematic Reviews . 2017 . 5 . CD009781 . May 2017 . 28516471 . 6481688 . 10.1002/14651858.CD009781.pub2 .
  22. Web site: WHO's cancer pain ladder for adults . World Health Organization (WHO) . 27 November 2013 . https://web.archive.org/web/20030807014332/http://www.who.int/cancer/palliative/painladder/en/ . dead . 7 August 2003 . 26 April 2020.
  23. Haroutiunian S, Drennan DA, Lipman AG . Topical NSAID therapy for musculoskeletal pain . Pain Medicine . 11 . 4 . 535–549 . April 2010 . 20210866 . 10.1111/j.1526-4637.2010.00809.x . free .
  24. Web site: Diclofenac Potassium . Drugs.com . 15 November 2015 . 4 October 2017 . https://web.archive.org/web/20171004060307/https://www.drugs.com/pro/diclofenac-potassium.html . live .
  25. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C . Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials . Lancet . 382 . 9894 . 769–779 . August 2013 . 23726390 . 3778977 . 10.1016/S0140-6736(13)60900-9 .
  26. FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications . U.S. Food and Drug Administration (FDA) . 15 October 2020 . 15 October 2020 . 16 October 2020 . https://web.archive.org/web/20201016180003/https://www.fda.gov/news-events/press-announcements/fda-warns-using-type-pain-and-fever-medication-second-half-pregnancy-could-lead-complications . live .
  27. Web site: NSAIDs may cause rare kidney problems in unborn babies . U.S. Food and Drug Administration . 21 July 2017 . 15 October 2020 . 17 October 2020 . https://web.archive.org/web/20201017014419/https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic . live .
  28. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C . Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials . BMJ . 332 . 7553 . 1302–1308 . June 2006 . 16740558 . 1473048 . 10.1136/bmj.332.7553.1302 .
  29. News: Heart risk warning over painkiller . 29 June 2013 . BBC News . 21 June 2018 . 20 September 2018 . https://web.archive.org/web/20180920110812/https://www.bbc.co.uk/news/health-23109314 . live .
  30. Web site: Press release: Diclofenac tablets now only available as a prescription medicine . 14 January 2015 . 14 January 2015 . Medicines and Healthcare products Regulatory Agency . 22 January 2015 . https://web.archive.org/web/20150122224346/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON500341 . live .
  31. Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S . Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk . Arthritis and Rheumatism . 54 . 5 . 1378–1389 . May 2006 . 16645966 . 10.1002/art.21887 . 2082359 .
  32. Fosbøl EL, Folke F, Jacobsen S, Rasmussen JN, Sørensen R, Schramm TK, Andersen SS, Rasmussen S, Poulsen HE, Køber L, Torp-Pedersen C, Gislason GH . Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals . Circulation: Cardiovascular Quality and Outcomes . 3 . 4 . 395–405 . July 2010 . 20530789 . 10.1161/CIRCOUTCOMES.109.861104 . free .
  33. FitzGerald GA, Patrono C . The coxibs, selective inhibitors of cyclooxygenase-2 . The New England Journal of Medicine . 345 . 6 . 433–442 . August 2001 . 11496855 . 10.1056/NEJM200108093450607 .
  34. Web site: Voltaren Gel (diclofenac sodium topical gel) 1% – Hepatic Effects Labeling Changes. . https://web.archive.org/web/20150329100526/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193047.htm . dead. 4 December 2009. 29 March 2015.
  35. Brater DC . Renal effects of cyclooxygyenase-2-selective inhibitors . Journal of Pain and Symptom Management . 23 . 4 Suppl . S15–20; discussion S21–23 . April 2002 . 11992745 . 10.1016/S0885-3924(02)00370-6 . free .
  36. Becker R. Cattle drug threatens thousands of vultures. Nature. 2016. 10.1038/nature.2016.19839. 75173071 .
  37. Web site: Diclofenac Side Effects . Drugs.com . 21 January 2013 . 5 February 2013 . https://web.archive.org/web/20130205085428/http://www.drugs.com/sfx/diclofenac-side-effects.html . live .
  38. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR . Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase . Proceedings of the National Academy of Sciences of the United States of America . 90 . 24 . 11693–11697 . December 1993 . 8265610 . 48050 . 10.1073/pnas.90.24.11693 . free . 1993PNAS...9011693M .
  39. Alfaro RA, Davis DD . 15 January 2024 . Diclofenac . 15 January 2024 . National Library of Medicine . 32491802 . 22 May 2023 .
  40. Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN . The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis . International Journal of Antimicrobial Agents . 14 . 3 . 249–251 . April 2000 . 10773497 . 10.1016/S0924-8579(99)00159-4 .
  41. Sandri A . Diclofenac: update on tolerableness and spinal anti-inflammatory action . Minerva Medica . 105 . 4 . 313–318 . August 2014 . 25078485 . 23 April 2023 . 23 April 2023 . https://web.archive.org/web/20230423165313/https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2014N04A0313 . live .
  42. Sandri A . Spinal antinflammatory action of Diclofenac . Minerva Medica . 107 . 3 . 167–172 . June 2016 . 27014880 . 23 April 2023 . 23 April 2023 . https://web.archive.org/web/20230423165313/https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2016N03A0167 . live .
  43. Gan TJ . Diclofenac: an update on its mechanism of action and safety profile . Current Medical Research and Opinion . 26 . 7 . 1715–1731 . July 2010 . 20470236 . 10.1185/03007995.2010.486301 .
  44. Ku EC, Lee W, Kothari HV, Scholer DW . Effect of diclofenac sodium on the arachidonic acid cascade . The American Journal of Medicine . 80 . 4B . 18–23 . April 1986 . 3085488 . 10.1016/0002-9343(86)90074-4 .
  45. Scholer DW, Ku EC, Boettcher I, Schweizer A . Pharmacology of diclofenac sodium . The American Journal of Medicine . 80 . 4B . 34–38 . April 1986 . 3085490 . 10.1016/0002-9343(86)90077-x .
  46. Cryer B, Feldman M . Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs . The American Journal of Medicine . 104 . 5 . 413–421 . May 1998 . 9626023 . 10.1016/S0002-9343(98)00091-6 .
  47. Fei XW, Liu LY, Xu JG, Zhang ZH, Mei YA . The non-steroidal anti-inflammatory drug, diclofenac, inhibits Na(+) current in rat myoblasts . Biochemical and Biophysical Research Communications . 346 . 4 . 1275–1283 . August 2006 . 16806078 . 10.1016/j.bbrc.2006.06.034 .
  48. Gwanyanya A, Macianskiene R, Mubagwa K . Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels . The Journal of Pharmacy and Pharmacology . 64 . 10 . 1359–1375 . October 2012 . 22943167 . 10.1111/j.2042-7158.2012.01479.x .
  49. Voilley N, de Weille J, Mamet J, Lazdunski M . Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors . The Journal of Neuroscience . 21 . 20 . 8026–8033 . October 2001 . 11588175 . 6763876 . 10.1523/JNEUROSCI.21-20-08026.2001 .
  50. Ortiz MI, Torres-López JE, Castañeda-Hernández G, Rosas R, Vidal-Cantú GC, Granados-Soto V . Pharmacological evidence for the activation of K(+) channels by diclofenac . European Journal of Pharmacology . 438 . 1–2 . 85–91 . March 2002 . 11906715 . 10.1016/S0014-2999(02)01288-8 .
  51. Fowler PD, Shadforth MF, Crook PR, John VA . Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis . European Journal of Clinical Pharmacology . 25 . 3 . 389–394 . 1983 . 6628528 . 10.1007/BF01037953 . 9803699 .
  52. Altman R, Bosch B, Brune K, Patrignani P, Young C . Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology . Drugs . 75 . 8 . 859–877 . May 2015 . 25963327 . 4445819 . 10.1007/s40265-015-0392-z .
  53. Hasan MK, Akhter S, Fatema K, Hossain MR, Sultana T, Uzzaman M . January 2023 . Selective modification of diclofenac to reduce the adverse effects; A computer-aided drug design approach . Informatics in Medicine Unlocked . 36 . 101159 . 10.1016/j.imu.2023.101159 . 2352-9148. free .
  54. Book: Fischer J . Analogue-based drug discovery. 517. 2006. Wiley-VCH. 978-3-527-31257-3.
  55. DE. 1793592. Process for the production of new substituted phenylacetic acids. Pfister R, Sallmann A. Ciba Geigy AG. 26 January 1978.
  56. Web site: Diclofenac. Drugs.com. 22 December 2018. 22 December 2018. https://web.archive.org/web/20181222173313/https://www.drugs.com/international/diclofenac.html. live.
  57. News: Connelly D. A breakdown of the over-the-counter medicines market in Britain in 2016. The Pharmaceutical Journal. 28 April 2017. 23 April 2023. 8 December 2021. https://web.archive.org/web/20211208124752/https://pharmaceutical-journal.com/article/infographics/a-breakdown-of-the-over-the-counter-medicines-market-in-britain-in-2016. live.
  58. Web site: Oral diclofenac presentations with legal status 'P' – reclassified to POM. www.gov.uk. 31 March 2015. 2 April 2015. https://web.archive.org/web/20150402164113/https://www.gov.uk/drug-device-alerts/drug-alert-oral-diclofenac-presentations-with-legal-status-p-reclassified-to-pom. live.
  59. Moreno-Opo R, Carapeto R, Casimiro R, Rubio C, Muñoz B, Moreno I, Aymerich M. The veterinary use of diclofenac and vulture conservation in Spain: Updated evidence and socio-ecological implications. The Science of the Total Environment. 796. 148851. 2021. 34271379. 10.1016/j.scitotenv.2021.148851. 2021ScTEn.79648851M .
  60. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJ, Arshad M, Mahmood S, Ali A, Khan AA . Diclofenac residues as the cause of vulture population decline in Pakistan . Nature . 427 . 6975 . 630–633 . February 2004 . 14745453 . 10.1038/nature02317 . 16146840 . 2004Natur.427..630O .
  61. Swan GE, Cuthbert R, Quevedo M, Green RE, Pain DJ, Bartels P, Cunningham AA, Duncan N, Meharg AA, Oaks JL, Parry-Jones J, Shultz S, Taggart MA, Verdoorn G, Wolter K . Toxicity of diclofenac to Gyps vultures . Biology Letters . 2 . 2 . 279–282. 2006 . 17148382 . 1618889 . 10.1098/rsbl.2005.0425 .
  62. Naidoo V, Swan GE. Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction . Comparative Biochemistry and Physiology. Toxicology & Pharmacology. 149. 3. 269–274. 2009. 18727958. 10.1016/j.cbpc.2008.07.014. free. 2263/13907.
  63. News: Vet drug 'killing Asian vultures'. BBC News. 28 February 2004. 25 August 2010. 3 December 2013. https://web.archive.org/web/20131203033409/http://news.bbc.co.uk/2/hi/science/nature/3437583.stm . live.
  64. Press Information Bureau, Government of India . 16 May 2005 . Saving the Vultures from Extinction . 12 May 2006 . 20 December 2005 . https://web.archive.org/web/20051220213802/http://pib.nic.in/release/release.asp?relid=9303 . live .
  65. Swan G, Naidoo V, Cuthbert R, Green RE, Pain DJ, Swarup D, Prakash V, Taggart M, Bekker L, Das D, Diekmann J, Diekmann M, Killian E, Meharg A, Patra RC, Saini M, Wolter K . Removing the threat of diclofenac to critically endangered Asian vultures . PLOS Biology. 4. 3. e66. 2006 . 16435886 . 1351921 . 10.1371/journal.pbio.0040066 . free .
  66. News: Eagles fall prey to vulture-killing chemical. Phadnis M . Pune Mirror. 28 May 2014. 28 May 2014. 29 May 2014. https://web.archive.org/web/20140529124248/http://www.punemirror.in/pune/others/Eagles-fall-prey-to-vulture-killing-chemical/articleshow/35639257.cms. live.
  67. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology. 68. 2. 141–150. 2004. 15145224. 10.1016/j.aquatox.2004.03.014. 2004AqTox..68..141S .
  68. Triebskorn R, Casper H, Heyd A, Eikemper R, Köhler HR, Schwaiger J . Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology. 68. 2. 151–166. 2004. 15145225. 10.1016/j.aquatox.2004.03.015. 2004AqTox..68..151T.
  69. Schwaiger J, Triebskorn R. Subletale Wirkungen von Arzneimitteln bei aquatischen Organismen. Sublethal effects of drugs in aquatic organisms. de. Texte. 29. 5. 2005. 217–226.
  70. Triebskorn R, Casper H, Scheil V, Schwaiger J . Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio) . Analytical and Bioanalytical Chemistry . 387 . 4 . 1405–1416. 2007 . 17216161 . 10.1007/s00216-006-1033-x . 21170569 .
  71. Rattner BA, Whitehead MA, Gasper G, Meteyer CU, Link WA, Taggart MA, Meharg AA, Pattee OH, Pain DJ . Apparent tolerance of turkey vultures (Cathartes aura) to the non-steroidal anti-inflammatory drug diclofenac . Environmental Toxicology and Chemistry . 27 . 11 . 2341–2345. 2008 . 18476752 . 10.1897/08-123.1 . 207267290 . 15 July 2019 . 28 August 2021 . https://web.archive.org/web/20210828062139/https://digitalcommons.unl.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=1977&context=usgsstaffpub . live .
  72. News: Walker M . Rabies tragedy follows loss of India's vultures . New Scientist . 6 August 2008 . 23 April 2023 . 23 April 2023 . https://web.archive.org/web/20230423164017/https://www.newscientist.com/article/mg19926684-400-rabies-tragedy-follows-loss-of-indias-vultures/ . live .
  73. News: 'Decline in vulture population has given rise to diseases': Dr Vibhu Prakash. 29 August 2016. 12 December 2018. The Indian Express. Choudhary S. 15 December 2018. https://web.archive.org/web/20181215222409/https://indianexpress.com/article/lifestyle/health/decline-in-vulture-population-has-given-rise-to-diseases-dr-vibhu-prakash-3001298/. live.
  74. Web site: E-010588/2015: answer given by Mr Andriukaitis on behalf of the Commission. European Parliament. 18 February 2024. 13 May 2016. https://web.archive.org/web/20160513232457/http://www.europarl.europa.eu/sides/getAllAnswers.do?reference=E-2015-010588&language=EN. live.
  75. Web site: Vulture killing drug now available on EU market. International BirdLife. 18 February 2024. 24 April 2014. https://web.archive.org/web/20140424125532/http://www.birdlife.org/europe-and-central-asia/news/vulture-killing-drug-now-available-eu-market. dead.
  76. Web site: First evidence of a vulture killed by veterinary diclofenac in Spain – will the Spanish government and the EU act after this smoking gun?. Vulture Conservation Foundation . 7 April 2021. 8 April 2021. 8 April 2021. https://web.archive.org/web/20210408082619/https://www.4vultures.org/first-evidence-of-a-vulture-killed-by-veterinary-diclofenac-in-spain/. dead.
  77. Web site: Fernholm A . 4 March 2010 . Val av smärtstillande påverkar miljön . 15 March 2023 . LäkemedelsVärlden . sv-SE . 15 August 2022 . https://web.archive.org/web/20220815220610/https://www.lakemedelsvarlden.se/val-av-smartstillande-paverkar-miljon/ . live .
  78. Web site: 10 September 2014 . Itämeren kalat häiriintyvät lääkeaineista – Teollisuudella paineita kehittää eettisempiä pillereitä . 15 March 2023 . Yle Uutiset . fi . 15 March 2023 . https://web.archive.org/web/20230315175230/https://yle.fi/a/3-7455669 . live .
  79. Hussain I, Khan MZ, Khan A, Javed I, Saleemi MK. Toxicological effects of diclofenac in four avian species. Avian Pathology. 37. 3. 315–321. 2008. 18568659. 10.1080/03079450802056439. 12985124. free.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Diclofenac".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.